A car dealer has helped a cancer centre put its chemotherapy on the road.

M53 Ford on Rossmore Road East, Ellesmere Port pulled out all the stops to help The Clatterbridge Cancer Centre deliver the treatment in the comfort of patients’ homes.

The dealership has donated a brand new, seven-seater Ford family car to the Clatterbridge Cancer Charity to enable the centre to expand its ‘Chemotherapy at Home’ project across Merseyside.

The initiative forms part of the ‘Clatterbridge in the Community’ scheme with the aim of improving health and wellbeing in the community through compassionate, safe and effective cancer care at home or closer to home.

M53 Ford director Carol McPhail said: “We are delighted to help The Clatterbridge Cancer Centre by supplying a suitable vehicle for nurses to travel to the homes of patients who are suitable for this new service.

“We all know someone who has been touched by cancer and, of course, many of those will have been treated by the dedicated teams at Clatterbridge.

“We are more than happy to help with this excellent project.”

Related: Hospice of the Good Shepherd gets new wheels

Delivered by skilled specialist nurses who travel from the centre to patients’ homes, the project offers a service that is flexible, able to meet individual needs and allows the trust to deliver more complex and novel treatments at its hospital sites.

The service is especially beneficial to patients who are unable to travel due to other medical needs, mental health issues or family responsibilities.

Patients can feel more relaxed and less stressed when chemotherapy is given at home with decreased anxiety over the need to reach hospital for a specific appointment time.

Maureen Ellison, trusts and major donor manager at The Clatterbridge Cancer Charity added: “We are hugely grateful to M53 Ford for this generous donation, which will make a real difference to cancer patients in this region.”

The centre has nine operating sites across Merseyside and Cheshire and is a leading provider of non-surgical oncology treatments including pioneering chemotherapy, radiotherapy and the UK’s only provider of proton therapy.

In 2013/14 there were nearly 221,000 contacts with over 30,000 individual patients.